PRESS RELEASE published on 04/27/2026 at 08:00, 6 months 15 days ago Capital B confirms the acquisition of 6 BTC for EUR 0.4 million, the holding of a total of 2,943 BTC, and a BTC Yield of 1.61% YTD Capital B completes capital increase at €0.65/share, acquires 6 BTC. Achieves BTC Yield of 1.61% YTD. Holds 2,943 BTC valued at €270.5M. Details on Bitcoin Treasury Company strategy available Capital Increase Bitcoin Treasury Company BTC Acquisition Capital B Yield Performance
PRESS RELEASE published on 04/27/2026 at 07:54, 6 months 15 days ago Healthcare players seek to establish the “Electronic Prescription Switzerland” service nationwide Swiss healthcare stakeholders collaborate to introduce 'Electronic Prescription Switzerland' service nationwide, promoting digitalisation of prescription process and e-medication E-prescriptions Digitalisation Swiss Healthcare Electronic Prescription Switzerland Healthcare Stakeholders
PRESS RELEASE published on 04/27/2026 at 07:47, 6 months 15 days ago EQS-Adhoc: CANCOM SE: Termination of the 2025 share buyback programme, cancellation of treasury shares and capital reduction CANCOM SE terminates 2025 share buyback program, cancels treasury shares, and reduces capital ahead of Annual General Meeting. Insider info disclosed in accordance with MAR Annual General Meeting Share Buyback Program Treasury Shares Capital Reduction CANCOM SE
PRESS RELEASE published on 04/27/2026 at 07:30, 6 months 15 days ago Mutares enters next phase of growth: Record-breaking pipeline on both the buy and sell sides meets strong results and maximum capital market support Mutares SE & Co. KGaA announces record-breaking growth phase with strong results, significant exit pipeline, and successful capital increase amid capital market support Capital Increase Record-breaking Mutares Growth Phase Exit Pipeline
PRESS RELEASE published on 04/27/2026 at 07:30, 6 months 15 days ago OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant Patients OSE Immunotherapeutics welcomes FDA Orphan Drug Designation granted to Pegrizeprument (VEL-101) for prevention of organ rejection in heart transplant patients, a novel immunomodulatory treatment developed in partnership with Veloxis Pharmaceuticals Orphan Drug Designation Transplant Pegrizeprument VEL-101 Organ Rejection
PRESS RELEASE published on 04/27/2026 at 07:30, 6 months 15 days ago FORVIA to Sell its Interiors Business Group to Apollo Funds FORVIA announces sale of Interiors Business Group to Apollo Funds for €1.82 billion, focusing on strategic initiatives and debt reduction Sale Debt Reduction Apollo Funds Forvia Interiors Business Group
PRESS RELEASE published on 04/27/2026 at 07:30, 6 months 15 days ago FORVIA: CHANGES TO THE COMPOSITION OF THE BOARD OF DIRECTORS OF FORVIA SUBJECT TO APPROVAL BY THE 2026 ANNUAL GENERAL MEETING FORVIA announces changes in Board of Directors composition with Pierre-André de Chalendar appointment and resignation of Michel de Rosen. Details on the 2026 Annual General Meeting Board Of Directors Annual General Meeting Resignation Forvia Pierre-André De Chalendar
PRESS RELEASE published on 04/27/2026 at 07:30, 6 months 15 days ago Exosens delivers strong Q1 2026 performance, with accelerating defense momentum in digital imaging and night vision; Fully on track to deliver on 2026 guidance Exosens reports strong Q1 2026 performance with accelerating defense momentum in digital imaging and night vision. On track to deliver on 2026 guidance Exosens Night Vision Q1 2026 Defense Momentum Digital Imaging
PRESS RELEASE published on 04/27/2026 at 07:00, 6 months 15 days ago Nordex Group reports solid Q1/2026 results with continued margin improvement year on year Nordex Group reports solid Q1/2026 results with continued margin improvement year on year. Sales growth, increased EBITDA, and positive net income. Full year 2026 guidance confirmed EBITDA Sales Growth Nordex Group Margin Improvement Q1/2026 Results
PRESS RELEASE published on 04/27/2026 at 06:50, 6 months 15 days ago Leclanché SA: Strengthens its Capital Structure through Debt-to-Equity Conversion Leclanché SA strengthens its capital structure through a debt-to-equity conversion, reinforcing its balance sheet with CHF 10 million converted to equity to support strategic growth initiatives Strategic Growth Balance Sheet Capital Structure Leclanché SA Debt-to-equity Conversion
Published on 11/13/2026 at 02:40, 2 hours 17 minutes ago Jaguar Mining Reports Third Quarter 2026 Results with 67% Growth in Adjusted Net Income and 46% Higher Adjusted EBITDA
Published on 11/13/2026 at 02:10, 2 hours 47 minutes ago Amarc to Participate in Consolidation of Aurora West Through Aurora Minerals LTD
Published on 11/12/2026 at 23:25, 5 hours 32 minutes ago Renegade Gold Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
Published on 11/12/2026 at 23:05, 5 hours 52 minutes ago Caldwell Reports Fourth Quarter and Full Year Fiscal 2026 Results; Increases Quarterly Dividend and Declares a Special Dividend
Published on 11/12/2026 at 23:00, 5 hours 57 minutes ago Redwood AI Announces Chemical Risk Analysis Update to its AI-Powered Reactosphere Platform to Support Faster Reaction Safety Screening
Published on 11/12/2026 at 23:10, 5 hours 47 minutes ago DeFi Technologies Inc. Announces Third Quarter 2026 Financial Results with Revenue of $18.3 Million, Operating Income of $7.0 Million, and Net Income of $22.3 Million
Published on 11/12/2026 at 22:35, 6 hours 22 minutes ago Silverfort Named a Leader in the IDC MarketScape for Worldwide Augmented Identity Security Solutions 2026 Vendor Assessment
Published on 11/12/2026 at 19:50, 9 hours 7 minutes ago Eurobattery Minerals receives shareholder requests for additional items on the agenda of the upcoming Extraordinary General Meeting
Published on 11/12/2026 at 18:25, 10 hours 32 minutes ago OMAN AWARDS TWO GREEN HYDROGEN PROJECTS IN DUQM AND LAUNCHES ROUND 4 GREEN-POWERED DATA CENTRE HYDROGEN AUCTION AT COP31
Published on 11/12/2026 at 18:14, 10 hours 43 minutes ago EQS-Adhoc: HUGO BOSS AG: Daniel Grieder to step down as CEO of HUGO BOSS effective December 31, 2026 - David Epstein appointed as CEO effective January 1, 2027
Published on 11/12/2026 at 23:12, 5 hours 44 minutes ago Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 18:36, 10 hours 20 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026
Published on 11/12/2026 at 18:00, 10 hours 57 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 12, 2026
Published on 11/12/2026 at 17:40, 11 hours 17 minutes ago Financial information for the period ended 30 September 2026
Published on 11/12/2026 at 08:56, 20 hours ago Number of shares and voting rights - October 2026 (In French only)